Use of bisphosphonates in the treatment of prostate cancer.
Olson
K B
KB
University of Michigan, Comprehensive Cancer Center, USA.
Pienta
K J
KJ
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010166:Palliative Care; D000077268:Pamidronate; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate